Published in Cancer Weekly, June 15th, 2004
According to published research from the United States, "Elevated prostate cancer incidence was found at a plant producing atrazine that had an intensive prostate screening program. This study tested the relationship among atrazine exposure, prostate cancer, and the screening program."
"Twelve cases and 130 control subjects were selected from the original cohort. Prostate screening and occupational histories were abstracted from company records and atrazine exposures were estimated," wrote P.A. Hessel and colleagues,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.